| Cell line | PPARγ agonist | Concentration | Results | Mechanism of action | Reference |
| UISO-Mel6, | Rosiglitazone, | 0.3–300 M | – Growth inhibition of all cell lines at | – Independent from apoptosis | Freudlsperger et al. [28] | MV3, MeWo, | pioglitazone, | 30–300 M, | G361, | ciglitazone, | – increase in cell
proliferation at | Lox | troglitazone | 3 M |
| MM-358, | 15d-PG, | 0.1–50 M | – Growth inhibtion of all cell lines at 20–50 M | – Independent from apoptosis, | Mössner et al. [29] | MM-201, | troglitazone, | – induction of G1 phase | MM-254, KAII | rosiglitazone | cell cycle arrest |
| SK-mel28, A375 | Ciglitazone, | 0–10 M | – Growth inhbition only of A375 at 10 M | – Not investigated | Eastham et al. [27] | troglitazone, | 15d-PG |
| WM35, A375 | Ciglitazone, | 10–15 M | – Growth inhibition of all cell lines at | – Induction of apoptosis | Placha et al. [30] | 15d-PG | 10–15 M |
| A375 | Ciglitazone, | 0–32 M | – Growth inhibtion of A375 at 16 M of 15d-PG | – Induction of apoptosis | Núñez et al. [31] | 15d-PG, | – no growth inhibition by ciglitazone |
|
|